Genetic analysis of cell-cell signaling in Saccharomyces cerevisiae has led to the identification of a novel factor, known as Sst2p, that promotes recovery after pheromone-induced growth arrest (R. K. Chan and C. A. Otte, Mol. Cell. Biol. 2:11-20, 1982). Loss-of-function mutations lead to increased pheromone sensitivity, but this phenotype is partially suppressed by overexpression of the G protein ␣ subunit gene (GPA1). Suppression is allele specific, however, suggesting that there is direct interaction between the two gene products. To test this model directly, we isolated and characterized several dominant gain-of-function mutants of SST2. These mutations block the normal pheromone response, including a loss of pheromone-stimulated gene transcription, cell cycle growth arrest, and G protein myristoylation. Although the SST2 mutations confer a pheromoneresistant phenotype, they do not prevent downstream activation by overexpression of G␤ (STE4), a constitutively active G␤ mutation (STE4 Hpl ), or a disruption of GPA1. None of the SST2 alleles affects the expression or stability of G␣. These results point to the G protein ␣ subunit as being the direct target of Sst2p action and underscore the importance of this novel desensitization factor in G-protein-mediated signaling.
The yeast Saccharomyces cerevisiae is a unicellular eukaryote that can grow vegetatively either as a diploid or as one of two haploid cell types, known as the mating types a and ␣. Haploid cells secrete specific peptide pheromones (a and ␣ mating factors) that act on cells of the opposite type to promote cell fusion, leading to the formation of an a/␣ diploid (28, 46) .
Pheromone signaling is mediated through receptors of the seven-transmembrane-segment class (other examples include the ␤-adrenergic receptor and rhodopsin) and is coupled to downstream events via a guanine nucleotide-binding regulatory protein (G protein) (28) . Agonist binding to these receptors promotes exchange of GDP for GTP on the G-protein ␣ subunit and dissociation of G␣ from the G protein ␤ and ␥ subunits (4, 6, 11) . In yeast cells, it is the ␤/␥ moiety that activates downstream signaling events leading to mating, which include alterations in gene transcription, morphological and cytoskeletal changes, and growth arrest in the G 1 phase of the cell cycle. Indeed, overexpression of the ␤ subunit or loss of the ␣ subunit leads to mating even in the absence of pheromone or receptor (13, 17, 25, 36, 39, 53) .
A property of signal-response systems in general, and of G-protein-coupled receptors in particular, is that prolonged stimulation often results in a loss of responsiveness over time (desensitization) (23) . The molecular basis for this phenomenon has been extensively characterized for vertebrate G-protein-coupled receptors (2, 32) and has also been described for S. cerevisiae (3, 8-10, 12, 16, 19, 27, 33, 37, 40, 41, 47) . Despite the profound physiological and morphological changes that yeast cells undergo in preparation for mating, cells that fail to mate become desensitized to the continued presence of pheromone and eventually resume growth as normal haploids (recovery).
Genetic analysis of the yeast mating response pathway has led to the identification of several mutations that affect pheromone sensitivity and desensitization (3, 8-10, 12, 16, 27, 29, 35, 37, 40, 41, 47, 49) . One such mutation in the SST2 gene (supersensitivity to pheromone), sst2-1, has no effect on normal cell growth but prevents recovery from pheromone-induced growth arrest (8, 9, 16) . Moreover, SST2 is expressed only in pheromone-responsive (haploid) cells, and expression is strongly induced by pheromone treatment (16, 18a) . These observations suggest that SST2 encodes a key regulatory component of the pheromone desensitization pathway. Recently, Madura and Varshavsky have reported that SST2 promotes degradation of Gpa1p via the N-end rule pathway, resulting in pheromone-independent growth arrest (34) .
Despite its critical role in pheromone desensitization, the point at which SST2 regulates the signal transduction cascade is not known. Here, we describe the isolation and characterization of a novel class of SST2 mutations that inhibit receptormediated signaling. A detailed genetic analysis of these and other alleles of SST2 reveals that Sst2p controls pheromone signaling through direct interactions with the G protein, Gpa1p.
MATERIALS AND METHODS
Strains, media, and transformation. The S. cerevisiae strains used in this study were RK512-5B (MATa ura3-52 his3-⌬1 ade2 - (44) , YDM400 (YPH499 sst2-⌬2) (from J. Thorner), YDK499 (YPH499 bar1::hisG) (from J. Thorner), YDK499-␤gal (YDK499 FUS1-lacZ) (transformed with the integrating plasmid pSB286, containing the bacterial lacZ gene under the control of the pheromone-inducible FUS1 promoter and URA3 as a selectable marker; from J. Trueheart) (50), YGS5 (YPHY99 gpa1::hisG ste11 ts ) (this work), DJ706-2-4 (MATa cry1 ade2-1 his4-580 lys2 trp1 try1 SUP4-3 leu2 ura3 ste5-3 STE4 Hpl ) (from D. Jenness) (3), and DC17 (MAT␣ his1). Escherichia coli DH5␣ was used for the maintenance of plasmids. Strain MH1066 (⌬lacX74 hsr rpsL pyrF::Tn5 leuB600 trpC9830 galE galK; from J. Boeke) was used to determine LEU2-complementing activity (see below). Standard methods for the growth and maintenance of yeast cells (21) and bacteria (1) were used. Yeast strains were grown in rich medium (YPD) or synthetic medium supplemented with amino acids, uracil, adenine, and 2% glucose (SCD) or 2% galactose plus 0.2% sucrose (SCG); nutrients were omitted to maintain selection for plasmids as necessary (e.g., SCD-Leu is SCD lacking leucine).
Plasmid construction and mutagenesis. Standard methods for the manipulation of DNA were used throughout (1) . The plasmids used in this study were pG1501, pG1501⌬, pRS315, pRS316, pAD4M, pRS315-GAL, pRS316-GAL, pRS315-SST2, pRS315-GAL-SST2, pRS316-GAL-STE4, pAD4M-SST2, and pAD4M-GPA1. pG1501 is a centromere-based shuttle vector containing URA3 as a selectable marker, the GAL1 promoter, GPA1, and the transcription termination region from TRP5 (35) . pG1501⌬ is identical to pG1501 but lacks the GPA1 gene (this work). pRS315 is a CEN vector derived from pBluescript (Stratagene) bearing the LEU2 marker (44) . pRS315-SST2 contains the 4.5-kb HindIII-HindIII fragment of the SST2 gene in pRS315 (16) . pRS315-GAL and pRS316-GAL contain the EcoRI-BamHI fragment of the GAL1/10 promoter at the corresponding sites within pRS315 and pRS316, respectively. pRS315-GAL-SST2 contains GAL1/10 followed by the 3.6-kb SST2 BamHI-HindIII fragment (mutant BamHI site at bp Ϫ33 relative to the initiator AUG) and a duplication of the HindIII-EcoRI cloning region from pBluescript. pRS316-GAL-STE4 was constructed by ligation of the EcoRI-SalI fragment from pL19 (containing GAL1/10 and STE4; from M. Whiteway [53] ) into pRS316. pAD4M is a 2m vector containing LEU2 and the ADH1 promoter and terminator (from P. McCabe, Cetus Corp.). pAD4M-GPA1 was constructed by ligation of a SmaI-SacI product of GPA1 in pBluescript (containing the XbaI-XbaI fragment from pG1501 [35] ) into the SmaI and SacI sites of pAD4M. pAD4M-SST2 was constructed by digestion of SST2 in pBluescript (HindIII-HindIII fragment) with SalI (mutant site at bp Ϫ55 relative to the initiator ATG) and SacI and ligation into the corresponding sites of pAD4M. The SST2 mutations were obtained by treating pRS315-GAL-SST2 with hydroxylamine and transforming E. coli MH1066 (to 96% survival; determined by replica plating to M9 medium lacking leucine, as described previously) (43) . Mutagenized plasmid DNA was prepared by scraping cells grown on ampicillin-containing LB plates, purified (Qiagen), and used to transform YDK499 by the method of Schiestl and Gietz (42) .
Growth inhibition by ␣-factor. To identify mutations in SST2 that confer resistance to ␣-factor, strain YDK499 was transformed with the library of mutagenized pRS315-GAL-SST2 plasmids and plated on SCG-Leu plus 2% agar (three 100-mm petri dishes; 16,000 colonies total). After 3 days, the colonies were replica stamped to SCG-Leu plates (ϳ30 ml) containing 300 g of synthetic ␣-factor (ϳ6 M concentration). Then 48 colonies were restreaked on SCG-Leu plates containing 100 g (ϳ2 M) of ␣-factor and, after 3 days, were replica stamped to SCG-Leu and SCD-Leu plates containing 100 g of ␣-factor. Of the 48 ␣-factor-resistant colonies, 5 appeared to be dependent on galactose induction. To verify that ␣-factor resistance was conferred by the plasmid, episomal DNA was prepared from all five colonies, amplified in E. coli, and used to retransform YDK499 (24) . Of the five plasmids tested, three were sufficiently ␣-factor resistant to warrant further study. All cultures exposed to ␣-factor were maintained at 24ЊC. However, none of the mutants were temperature dependent (tested at 24, 30, and 34ЊC), and all subsequent experiments were performed at 30ЊC.
The growth inhibition assay (halo assay) was described previously (21, 45) . Briefly, cells were transformed with either pG1501, pG1501⌬, pRS315, pRS315-GAL, pRS315-SST2, or pRS315-GAL-SST2 (including mutant alleles). An overnight culture of each transformant (in SCD-Leu or SCD-Ura) was diluted (1:40) into 2 ml of SCD-Leu, SCG-Leu, or SCG-Ura, followed by the addition of an equal volume of 1% (wt/vol) dissolved agar (50ЊC), and spread onto a culture dish of the same medium. Sterile filter disks were spotted with synthetic ␣-factor (0.5 or 1.5 g for YDK499; 5 or 15 g for YPH499, and YDM400; 0.3, 1, or 3 g for all other strains) and placed on the nascent lawn. The resulting halo of growth-arrested cells surrounding the source of ␣-factor was photographed after 3 days at 30ЊC.
Growth in the presence of pRS316-GAL or pRS316-GAL-STE4 (coexpressed with pRS315-GAL-SST2 plasmids in YDK499) was determined by spotting 10 l of an overnight culture (in SCD-Ura-Leu) onto SCD-Ura-Leu or SCG-Ura-Leu plates and streaking out the nascent colonies. In some cases, a 600 nM concentration of ␣-factor was added to the plates, as indicated. The growth of strains DJ706-2-4 and YGS5 carrying pRS315-GAL or pRS315-GAL containing wildtype or mutant SST2 was determined in the same manner except that these temperature-sensitive strains were grown initially at the permissive temperature and then spotted to SCG-Leu plates at either the restrictive or permissive temperature, as indicated. The resulting colony growth was documented after 3 days.
DNA sequencing. Base substitutions were determined by oligonucleotideprimed double-stranded DNA sequencing (US Biochemicals Sequenase version 2.0, used according to the manufacturer's instructions). All of the sequences match that of the previously published wild-type SST2 sequence (16) , except for the following codon substitutions: CCG3CTG, encoding a Pro-for-Leu substitution at position 20 (SST2-1, SST2-2, and SST2-3), and GGA3AGA, encoding a Gly-for-Arg substitution at position 22 (SST2-2 and SST2-3). Thus, SST2-2 and SST2-3 are identical within their coding regions. In addition, the wild type and all three mutants differed from the published sequence at codons 615 and 616, where ACC GAT (Thr-Asp) was replaced by ACG CAT (Thr-His).
Immunoblot analysis. Strains YDK499, YPH499, and YDM400 were transformed with plasmid pRS315-GAL or pAD4M containing either no insert, wildtype SST2, or mutant SST2 alleles. Transformed cells were grown in SCD-Leu or SCG-Leu medium, as indicated. In some cases, cells were treated with 5 M synthetic ␣-factor for 1 h. Cell extracts from strains RK512-5B, BC138, BC159, and BC180 were prepared in the same manner except that cells were not transformed and were maintained in rich medium (YPD). To monitor the loss of Gpa1p over time, cells were treated with cycloheximide (10 g/ml in 0.1% ethanol, final concentrations) for 1 to 4 h. In the course of membrane fractionation and immunoprecipitation studies, we have found Gpa1p to be difficult to solubilize and susceptible to degradation following cell lysis (18a). Therefore, an advantage of this method is that treated cells are lysed directly in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer at 100ЊC (see below), resulting in complete solubilization and protease inactivation, allowing total cellular Gpa1p to be determined by immunoblotting. Cell growth was stopped at mid-logarithmic phase by the addition of NaN 3 (10 mM final) and chilling, and the cells were harvested by centrifugation (4ЊC). Cells were resuspended in 5 mM NaN 3 , and equivalent numbers of cells were transferred to 1.5-ml Eppendorf tubes and centrifuged briefly. The resulting cell pellets were resuspended in a fourfold excess volume of SDS-PAGE lysis buffer (0.05 M Tris-HCl [pH 6.8], 1% SDS, 1% 2-mercaptoethanol, 10% glycerol, 0.0015% bromophenol blue), boiled for 10 min, and subjected to Vortex homogenization with glass beads (0.50 mm) for 4 min. The resulting extracts were then resolved by SDS-PAGE with a Bio-Rad MiniProtean apparatus according to the manufacturer's instructions, electrophoretically transferred to nitrocellulose, and probed with polyclonal anti-Sst2p or anti-Gpa1p antiserum (18, 18a) and horseradish peroxidase-conjugated anti-rabbit immunoglobulin G (IgG; Bio-Rad) (1). The second antibody was detected by using Kodak XAR5 film and the Amersham enhanced chemiluminescence detection reagent, with the transfer, hybridization, and wash conditions recommended by the manufacturer.
Transcription analysis. Strain YDK499-␤gal was transformed with plasmid pRS315-GAL containing no insert, wild-type SST2, or the mutant alleles of SST2. Cells were grown to mid-log phase in SCG-Leu medium and treated with 1 to 300 nM ␣-factor for 90 min. Cells (1.4 ml) were harvested and resuspended in 1 ml of Z buffer (0.1 M NaPO 4 [pH 7.0], 10 mM KCl, 1 mM MgSO 4 , 50 mM 2-mercaptoethanol) with 0.5% (vol/vol) chloroform and 0.005% (wt/vol) SDS. After 15 min at 30ЊC, 0.2 ml of the o-nitrophenyl-␤-D-galactoside substrate in Z buffer was added (0.225 mM final concentration). After 90 min, the reaction was stopped with the addition of 0.5 ml Na 2 CO 3 (0.4 M final concentration). ␤-Galactosidase activity units are expressed as the ratio of o-nitrophenol product to cell density determined colorimetrically (optical density at 420 nm [OD 420 ]/ OD 600 ), as described by Guarente (20) .
Analysis of mating competence. Quantitative mating assays were performed as described previously (45) . Briefly, MATa and MAT␣ cells were grown to mid-log phase in SCG-Leu, mixed at a ratio of 10:1 with the DC17 tester strain in excess, and collected onto sterile membranes by vacuum filtration. The filtered cells were placed on a YPG plate overnight, resuspended in water, and plated to various dilutions on synthetic medium containing 2% galactose and 0.2% sucrose but lacking amino acids and uracil to select for diploids (SG medium). The relative mating efficiencies of strains bearing the SST2 mutations in pRS315-GAL were calculated by counting diploids and are expressed relative to that of wild-type (pRS315-GAL-SST2-transformed) cells.
RESULTS

Overexpression of GPA1 restores recovery in sst2 mutants.
To characterize the role of SST2 in pheromone desensitization, we used the growth inhibition assay (halo assay) to compare the effects of GPA1 overexpression on a variety of known sst2 mutants (21, 26) . In this procedure, cells are plated on solid medium and exposed to ␣-mating factor spotted on sterile filter disks. Differences in the zone of inhibition (halo size and turbidity) are indicative of a particular strain's ability to arrest, desensitize, and resume growth within the time period of the assay (typically 2 to 5 days).
Four strains were tested: one in which a complete disruption of SST2 had been generated in vitro (sst2-⌬2), two carrying alleles previously isolated in a genetic screen for supersensitivity (sst2-1 and sst2-4), and a wild-type strain (9, 15) . As shown in Fig. 1A , wild-type cells exhibit small turbid halos that rapidly fill in, the sst2-1 (missense) and sst2-⌬2 (disruption) mutants yield large clear halos of similar size that never fill in, and the sst2-4 (nonsense) mutant exhibits clear halos of intermediate size. Immunoblot analysis reveals that sst2-1 cells pro-duce a specific product of the same molecular weight as Sst2p, indicating that the mutant gene is expressed and may retain some function (Fig. 1B) .
When GPA1 is overexpressed in these strains, smaller and more turbid halos are observed in every case, indicating an enhanced ability to desensitize (Fig. 1A, left) . One interpretation of this effect is that increased Gpa1p expression leads to sequestration of ␤/␥ and a reduced overall response to pheromone, independent of any effects of SST2 (17, 28) .
However, the data in Fig. 1A also reveal that suppression is allele dependent with regard to SST2. Whereas the sst2-1 and sst2-⌬2 mutants normally respond equally to pheromone, the sst2-1 mutant becomes much less sensitive when GPA1 is overexpressed. This difference is difficult to explain simply in terms of the ␤/␥ sequestration model described above. Rather, we favor an alternative model in which Sst2p and Gpa1p interact to promote desensitization. The sst2-1 gene product may be partially unfolded or mislocalized under normal circumstances but can form a stable or functional complex when Gpa1p is overexpressed.
Isolation of dominant inhibitory SST2 mutations. Allelespecific suppression of sst2 by GPA1 suggests that the products of these genes interact. Thus, we devised a genetic strategy to test this model directly. We reasoned that if loss-of-function mutations in SST2 amplify pheromone signaling, gain-of-function mutations that block signaling in a dominant manner could be obtained. By activating the signal at various points throughout the pathway, the dominant inhibitory mutations could then be used to establish where Sst2p operates. If Sst2p indeed acts directly on the G protein, gain-of-function mutations should block signaling through the receptor but not activating mutations in the G protein. An added advantage is that sequencing and phenotypic characterization of dominant gene mutations can provide useful information about structurefunction relationships that is not available from simple gene knockout or overexpression experiments.
The following strategy was used to identify SST2 mutations that inhibit pheromone signaling. Strain YDK499 was transformed with a hydroxylamine-mutagenized plasmid containing SST2 under the control of the GAL1 promoter (pRS315-GAL-SST2), as described in Materials and Methods. After transformation and several days of growth on galactose-containing medium, the colonies were replica stamped to plates containing very high (normally lethal) concentrations of ␣-factor (ϳ6 M). To verify that any surviving ␣-factor-resistant colonies were dependent on SST2 expression, they were restreaked on ␣-factor-containing plates and replica stamped to dextrose-or galactose-containing medium (to repress or induce gene expression, respectively) in the presence of ␣-factor. To verify that growth was conferred by the plasmid, episomal DNA was prepared from all surviving (galactose-dependent) colonies, amplified in E. coli, and used to retransform the original YDK499 strain. Plasmids pRS315-GAL (lacking the SST2 gene) and pRS315-GAL-SST2 (wild-type SST2 gene) were used as negative controls. After these manipulations, three clones were sufficiently ␣-factor resistant to warrant further study and were designated SST2-1, SST2-2, and SST2-3.
Sequencing of SST2 mutations. To determine the structural basis for the change in ␣-factor sensitivity, the entire SST2 coding region of the wild type and clones SST2-1, SST2-2, and SST2-3 was sequenced as described in Materials and Methods. All three mutants differ from the wild type at codon 20, where CCG (Pro) was replaced with CTG (Leu). In addition, SST2-2 and SST2-3 carry a substitution at codon 22, where GGA (Gly) has been changed to AGA (Arg). Both missense mutations are likely due to hydroxylamine treatment, which hydroxylates cytidine and leads to mispairing with adenine (43) .
SST2 mutations prevent ␣-factor-dependent growth arrest. In order to characterize the role of SST2 in desensitization, pheromone sensitivity was evaluated by the halo assay. Whereas wild-type cells normally exhibit small turbid halos that rapidly fill in (consistent with their ability to desensitize, FIG. 1. Allele-dependent suppression of sst2 mutations by GPA1. (A) Strains carrying various alleles of SST2 were transformed with a high-copy vector containing GPA1 under control of the GAL1/10 promoter (pG1501; Gpa1 overexpressed) or the parent vector alone (right). The strains either have a complete disruption of SST2 generated in vitro (sst2-⌬2) or express either the wild-type SST2 gene (SST2) or one of two missense alleles previously isolated in a genetic screen for supersensitivity (sst2-1 or sst2-4). Individual transformants were plated as a nascent lawn on galactose selective plates, exposed to ␣-factor, and photographed after 3 days at 30ЊC. The order of sensitivity is altered by GPA1 overexpression in an sst2 allele-specific manner, as indicated by relative halo size:
Immunoblotting was used to detect the wild-type (SST2) and any expressed mutant (sst2-1, sst2-4, and sst2-⌬2) gene products, as detailed under Materials and Methods. Cells were grown in YPD medium to the mid-logarithmic phase, collected, homogenized, and resolved by SDS-PAGE and electrophoretic transfer to nitrocellulose. The anti-Sst2p antiserum detects a single major band of ϳ82 kDa, corresponding to the SST2 gene product (Sst2p), and is induced by pheromone (␣-mating factor, ␣-MF) addition (5 M, 1 h). These data indicate that the sst2-1 mutant product is expressed as a full-length product.
VOL. 15, 1995 YEAST DESENSITIZATION MUTANTS 3637 Fig. 1A ), YDK499 exhibits large clear halos that do not fill in (because of the absence of BAR1, the ␣-factor-specific protease) (8) (9) (10) 33) . To avoid the confounding effects of BAR1 expression, strain YDK499 was used for most of the experiments described below. When overexpressed in YDK499, wild-type SST2 yields slightly smaller and more turbid halos, consistent with its role in mediating desensitization ( Fig. 2A , pGAL:SST2 versus vector). Transformation with SST2-1 yields extremely turbid halos, indicating a greatly enhanced ability to desensitize (pGAL: SST2-1). This effect is absolutely dependent on galactose induction, since it is blocked by growth in dextrose (pGAL: SST2-1 ϩ dextrose). Identical results were obtained for SST2-2 and SST2-3 (data not shown). Loss of ␣-factor sensitivity was also observed with all three mutant alleles expressed in a BAR1 (YPH499) strain as well as in an sst2-⌬2 (YDM400) mutant, as expected for a true dominant allele (data not shown).
The SST2 mutations were isolated based on their ability to block pheromone-induced growth arrest when overexpressed under control of the galactose-inducible GAL1 promoter. Accordingly, we tested whether ''normal'' levels of expression would also confer ␣-factor resistance. As shown in Fig. 2B , we performed halo assays on each of the mutants expressed from a single-copy plasmid containing the wild-type SST2 promoter. Compared with the wild type, SST2-1 and SST2-2 yield smaller and considerably more turbid halos (Fig. 2B , pSST2 versus pSST2-1 and pSST2-2). Identical results were obtained for SST2-3 (data not shown). These data indicate that the Pro-20 to Leu mutation in Sst2p results in a greatly attenuated pheromone response but that overexpression is required to fully block signaling.
Equal expression of wild-type and mutant alleles of SST2. As shown in Fig. 2 , overexpression of wild-type SST2 can promote recovery from pheromone-induced growth arrest, as manifested by more turbid halos after prolonged exposure to ␣-factor. To rule out the possibility that the pheromone-resistant phenotype displayed by the SST2 mutants results from gross overexpression (e.g., due to a mutation that stabilizes mRNA or protein), expression of the SST2 products was evaluated by immunoblotting.
Transformed yeast cultures were grown in either dextrose or galactose, harvested, and prepared for SDS-PAGE and immunoblotting as detailed under Materials and Methods. As shown in Fig. 3 , anti-Sst2p antibodies detect a prominent protein species of ϳ82 kDa. Moreover, all three mutant products are expressed at levels comparable to wild-type Sst2p, and expression is dependent on galactose induction (Fig. 3) . Untransformed cells treated with ␣-factor also express an 82-kDa SST2 product which is absent in the sst2-⌬2 mutant strain (Fig. 1) .
SST2 mutations attenuate pheromone-dependent gene induction. There are several caveats to using the halo assay described above for measuring the response to ␣-factor. For example, the effects on growth are measured over several days and may not reflect short-term changes in pheromone responsiveness. Moreover, differences in ''turbidity'' are difficult to quantitate. One short-term assay that is amenable to quantitation is pheromone-dependent gene transcription. This is conveniently done with a reporter gene (␤-galactosidase) under the control of a pheromone-responsive gene promoter (from FUS1) (45, 50) .
As shown in Fig. 4 , we used the ␤-galactosidase assay to test the ability of the SST2 alleles to attenuate pheromone-dependent gene transcription. Strain YDK499-␤gal was transformed with either vector alone, wild-type SST2, or mutant SST2 plasmids, as detailed under Materials and Methods. Cells were treated for 90 min with ␣-factor at concentrations ranging from 1 to 300 nM. Compared with cells transformed with the vector alone, overexpression of wild-type SST2 leads to a modest reduction in ␤-galactosidase induction, with a Ͻ2-fold change in the 50% effective concentration (EC 50 ) for the ligand.
FIG. 2. SST2
suppression of ␣-factor-induced growth arrest. The halo assay was used to evaluate the ability of wild-type and pheromone-unresponsive SST2 mutants to respond and desensitize to ␣-factor. (A) As detailed under Materials and Methods, plasmid pRS315-GAL (vector) or pRS315-GAL containing SST2 (pGAL:SST2) or SST2-1 (pGAL:SST2-1) was introduced into strain YDK499. Transformed cells were plated as a nascent lawn on selective plates containing galactose or dextrose, as indicated. Lawns were exposed to ␣-factor and photographed after 3 days at 30ЊC. Pheromone responsiveness was reduced by SST2 and blocked by SST2-1 overexpression, as indicated by relative halo size and turbidity. (B) To determine if overexpression contributes to the loss of pheromone signaling, mutations were expressed from a single-copy plasmid with the wild-type SST2 promoter. Compared with the wild type, SST2-1 and SST2-2 yield slightly smaller and considerably more turbid halos (pSST2 versus pSST2-1 and pSST2-2), indicating that the SST2 mutations must be overexpressed to fully block signaling. FIG. 3 . Immunodetection of Sst2p. Immunoblotting was used to detect the wild-type (SST2) and mutant products, as detailed under Materials and Methods. Cells were grown in dextrose (lanes -) or galactose (lanes ϩ) to mid-log phase, collected, homogenized, and resolved by SDS-PAGE and electrophoretic transfer to nitrocellulose. The anti-Sst2p antiserum detects a single major band of ϳ82 kDa, corresponding to the SST2 gene product (Sst2p), and is dependent on galactose induction. These data indicate that the wild-type and SST2 mutant products are expressed at comparable levels following galactose induction.
Moreover, overexpression of mutant SST2 leads to a virtually complete loss of ␤-galactosidase induction (Fig. 4) , which is evident even at very high ␣-factor concentrations (5 M) (data not shown). This reduction in the biological efficacy but not the potency of the agonist is typical of what is observed after desensitization of mammalian G-protein-coupled receptors (2, 23, 32) .
SST2 mutations do not prevent mating. A number of recessive mutations that block pheromone signaling have been described previously. Many of these result in a pheromone-unresponsive phenotype and an inability to mate (sterile phenotype). These include genes for the mating factor receptors (STE2 and STE3) (7, 22, 38) and the G protein ␤ and ␥ (STE4 and STE18) subunits (52) . To determine whether cells carrying the dominant SST2 mutations are similarly impaired in their ability to mate, a quantitative mating assay was performed (Table 1) . Transformed MATa cells (YDK499) were mixed with a 10-fold excess of a MAT␣ tester strain, DC17, and plated on SG medium to select diploids, as described under Materials and Methods. The relative mating efficiencies of cells bearing the mutant SST2 alleles (or vector alone) were calculated relative to those of cells transformed with wild-type SST2. Since bar1 mutants mate with a reduced efficiency relative to wild-type cells, we also tested an isogenic BAR1 strain, with similar results (YPH499, Table 1 ).
Despite the profound loss of pheromone responsiveness observed in other assays ( Fig. 2 and 4) , the mating efficiencies of cells bearing the SST2 mutations were comparable to that of the wild type, within 30% in every case (Table 1) . Although these results seem paradoxical, they were not entirely unexpected. An sst2-1 mutant strain was reported to be ϳ100-fold more sensitive than the wild type by the halo assay, but 10-to 30-fold less likely to mate (9) . Thus, the dominant inhibitory alleles of SST2 appear to have a phenotype opposite that of sst2, exhibiting a greatly reduced sensitivity to pheromone but an unimpaired ability to mate.
SST2 mutations do not prevent growth arrest following direct G-protein activation. Any mutation that compensates for some other mutation, resulting in a normal phenotype in the double mutant, is known as a suppressor allele. Suppressor alleles can be extremely useful in ordering components in a signaling pathway. Accordingly, we examined whether the SST2 mutations could suppress signaling by the G protein as well as the receptor. If Sst2p interacts directly with Gpa1p, our gain-of-function mutations should not inhibit signaling in the absence of protein (gpa1⌬ mutant) or if signal regulation is subverted by overexpression or constitutively active mutants of ␤/␥.
As shown in Fig. 5A , strain YDK499 was cotransformed with plasmids containing STE4 and either wild-type or mutant SST2, each under the control of the GAL promoter. Cells were first grown in dextrose-containing liquid cultures and then spotted and streaked onto galactose-containing medium (in some cases supplemented with ␣-factor). As anticipated, galactose induction of STE4 expression (Fig. 5A , galactose, octants 1 to 4) and treatment with high concentrations of pheromone (galactose ϩ ␣-factor) led to permanent growth arrest. However, whereas the SST2 mutations restored growth in ␣-factor-containing medium (Fig. 5A , galactose ϩ ␣-factor, octants 5 to 7), they were not able to restore growth in G␤-overexpressing cells, whether or not ␣-factor was present (Fig.  5A , galactose and galactose ϩ ␣-factor, octants 2 to 4). The SST2 mutations also conferred ␣-factor resistance in cells carrying a second plasmid with the GAL promoter but lacking STE4 (octants 5 to 7 versus octant 8, pGAL:vector), ruling out any confounding effects of competition for promoter binding. 
STE4
Hpl encodes a dominant constitutively active G␤ mutation that leads to pheromone-independent signaling and growth arrest. Strain DJ706-2-4 also carries a downstream temperature-sensitive mutation in STE5 (ste5-3), which blocks signaling by STE4
Hpl when maintained at 34ЊC (the permissive temperature) but not at 24ЊC (restrictive temperature). As shown in   FIG. 4 . ␤-Galactosidase induction in cells overexpressing wild-type and mutant alleles of SST2. Strain YDK499 (bar1⌬) was transformed with the integrating plasmid pSB286, containing the bacterial lacZ gene under the control of the pheromone-inducible FUS1 promoter, followed by transformation with pRS315-GAL alone (vector) or containing wild-type SST2 or the SST2 mutant SST2-1, SST2-2, or SST2-3. Cells were grown to mid-logarithmic phase in galactosecontaining medium and treated with 1 to 300 nM ␣-factor for 90 min, as indicated. Cells were harvested and tested for induction of ␤-galactosidase activity, as detailed under Materials and Methods. ␤-Galactosidase units are expressed as the ratio of o-nitrophenol product to cell density (determined colorimetrically; OD 420 /OD 600 ). Individual data points (duplicates) were plotted, and an interpolating line was drawn for each series. The experiment is representative of results obtained from two independent transformants. ␣-Factor sensitivity is reduced by the overexpression of SST2 and is abolished by the SST2 mutations. a Mating efficiencies for SST2 mutants in the vector pRS315-GAL, expressed in strain YPH499 or YDK499 (bar1). Values represent the number of diploids formed as a percentage of the wild-type number (pRS315-GAL-SST2). Values are averages from two independent experiments, in which Ͼ250 colonies were counted.
b ND, not determined.
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Fig
. 5B, cells were first grown in galactose at 34ЊC and then streaked onto galactose-containing plates at either at 34 or 24ЊC. As anticipated, cells maintained at 34ЊC grew in the presence or absence of the SST2-containing plasmids. However, neither SST2-1 nor SST2-2 was able to restore growth when the cells were shifted to 24ЊC. The experiments in Fig. 5C were designed to test whether the SST2 mutations could suppress another type of constitutive signaling mutation, disruption of GPA1 (strain YGS5). The absence of G␣ in YGS5 leads to unregulated expression of free ␤/␥ and persistent signaling in the absence of pheromone. Strain YGS5 carries a downstream temperature-sensitive mutation in STE11 which blocks growth arrest when maintained at 34ЊC (the permissive temperature) but not at 24ЊC (restrictive temperature). As shown in Fig. 5C , cells carrying GPA1 (positive control), wild-type SST2, SST2-1, SST2-2, or vector alone (negative control) were grown in galactose at 34ЊC and then spotted and streaked onto galactose-containing plates at either 34 or 24ЊC. Whereas all of the transformed cells grew at 34ЊC, only GPA1 conferred growth at 24ЊC. Thus, whereas the SST2 mutations block ␣-factor-dependent growth arrest, they are ineffective at blocking G-protein-mediated signaling.
SST2 regulation of Gpa1p expression. The data presented in Fig. 5 demonstrate that STE4 and GPA1 are epistatic to SST2, suggesting that Sst2p acts on the receptor or G protein. A recent report from Madura and Varshavsky (34) reveals a possible mode of action for Sst2p. These investigators have shown that overexpression of the ubiquitin-conjugating enzymes in yeast cells leads to increased turnover of Gpa1p and inhibition of cell growth and that this phenotype is suppressed by an sst2⌬ mutation. The authors proposed (but did not show) that Sst2p acts to destabilize Gpa1p. A paradox of this model is that SST2 mutants are more sensitive to ␣-factor, but elevating Gpa1p expression reduces ␣-factor sensitivity (e.g., Fig.  1 ). Moreover, Gpa1p turnover was monitored by using overexpressed epitope-tagged protein, and only in the absence of pheromone. Since the epitope tags were placed at the functionally important amino and carboxy termini of the protein, Gpa1p should not be functional (14) . Since SST2 transcription FIG. 5 . SST2 suppression of pheromone-induced but not G-protein-induced growth arrest. Epistasis analysis was used to determine if the SST2 mutants suppress signaling by the G protein as well as by the receptor. (A) Strain YDK499 was cotransformed with plasmid pRS316-GAL (octants 5 to 8, pGAL: vector) or pRS316-GAL-STE4 (octants 1 to 4, pGAL:STE4, overexpressing G␤) and with pRS315-GAL bearing wild-type or mutant SST2. Transformed cells were grown in dextrose-containing liquid cultures and then spotted and streaked onto galactose or dextrose-containing plates, in some cases supplemented with ␣-factor. Whereas SST2 mutants restored growth in ␣-factor-containing medium (galactose ϩ ␣-factor, octants 5 to 7 versus octant 8), they were not able to restore growth to STE4-overexpressing cells (galactose, octants 2 to 4) or STE4-overexpressing cells treated with ␣-factor (galactose ϩ ␣-factor, octants 2 to 4). No growth was observed for cells treated with ␣-factor under noninducing conditions (dextrose ϩ ␣-factor, octants 1 to 8). (B) To rule out the possibility that overexpression of Ste4p interferes with Sst2p function, strain DJ706-2-4 (STE4 Hpl ste5-3) was transformed with pRS315-GAL bearing wild-type SST2 (pGAL:SST2) mutant SST2 (pGAL:SST2-1 or pGAL:SST2-2), or no insert (pGAL:vector).
STE4
Hpl encodes a dominant constitutively active G␤ mutant that causes pheromone-independent signaling and growth arrest at the restrictive temperature (24ЊC; ste5-3). Transformed cells were grown in galactose at the permissive temperature and then streaked onto galactose-containing plates at either 34 or 24ЊC. The SST2 mutants did not restore growth to the STE4 Hpl -arrested cells. (C) To test whether SST2 mutants could suppress constitutive signaling resulting from a disruption of GPA1, strain YGS5 was transformed with pRS315-GAL bearing wild-type (pGAL:SST2) or mutant SST2 (pGAL:SST2-1 or pGAL:SST2-2) or no insert (pGAL:vector). A GPA1 plasmid was used as a positive control. YGS5 carries a downstream temperature-sensitive mutation in STE11 that blocks signaling at 34ЊC (permissive temperature). Transformed cells were grown in galactose at the permissive temperature and then streaked onto galactose-containing plates at either 34 or 24ЊC. The SST2 mutants did not restore growth to the gpa1⌬-arrested cells.
is highly dependent on pheromone induction, very little protein would be expressed (Fig. 1) (16) .
The experiments in Fig. 6 were designed to test whether SST2 can influence the expression of endogenous functional Gpa1p and whether expression is affected by pheromone stimulation. Initially, we examined Gpa1p in strains YPH499, YDM400 (sst2-⌬2), and YDM400 overexpressing wild-type SST2 or SST2-1, grown in the presence or absence of 5 M ␣-factor. As shown in Fig. 6A , the Gpa1p antibodies recognize two species of Gpa1p, representing the myristoylated (ϳ54 kDa) and unmyristoylated (ϳ56 kDa) forms of the protein (48) . Only the myristoylated species is capable of binding to ␤/␥, since a mutation that blocks this modification (gpa1 Gly2Ala ) cannot complement the loss of GPA1 (48) . Moreover, it was previously shown that ␣-factor stimulation leads to an increase in Gpa1p myristoylation (18) . In agreement with those findings, we detect an increase in the myristoylated 54-kDa species in cells treated with pheromone, and the extent of pheromonestimulated myristoylation correlates well with pheromone-dependent growth arrest and transcription (i.e., sst2⌬ Ͼ SST2 Ͼ SST2-1). However, there is little or no effect of SST2 on overall Gpa1p expression. Overexpression of SST2 and SST2-1 was confirmed by immunoblotting the same extracts with SST2 antibodies (data not shown).
To determine if SST2 affects Gpa1p stability, we examined cells grown in the presence or absence of 5 M ␣-factor for 1 h and then treated with cycloheximide to block new protein synthesis. Immunoblot analysis revealed that cells bearing an SST2 disruption or wild-type SST2 do not differ significantly in the rate of loss of myristoylated (i.e., functional) Gpa1p after cycloheximide addition (Fig. 6B and C) . Indeed, the loss of unmyristoylated Gpa1p appears to be somewhat reduced in wild-type cells compared with cells bearing sst2-⌬2. As before, differences in the levels of myristoylated and unmyristoylated protein correlate with ␣-factor sensitivity. To determine if SST2-1 influences Gpa1p turnover, expression of genomic Gpa1p was monitored following ␣-factor stimulation and cycloheximide administration. Immunoblots prepared from cells overexpressing wild-type SST2 or SST2-1 reveal little difference in Gpa1p degradation (data not shown). We conclude that while turnover of functional, myristoylated Gpa1p is indeed rapid, overall expression or stability is not significantly affected by SST2.
DISCUSSION
Desensitization is an important phenomenon in biology and has been extensively characterized for a number of vertebrate receptors, such as the ␤-adrenergic receptor and rhodopsin. Receptor desensitization is thought to represent the molecular basis for attenuation to light, odors, chemical stimulants, and narcotics and is also a factor that limits the efficacy of therapeutic drugs (31) .
The mechanisms of receptor desensitization are complex and include rapid alterations, such as receptor phosphorylation, uncoupling from the G protein, and protein sequestration within minutes of agonist activation (2, 19, 23, 31, 32) . Like vertebrate cells, yeast cells become desensitized to the continued presence of pheromone and will eventually recover from pheromone-induced G 1 growth arrest (3, 8-10, 12, 16, 19, 27, 33, 37, 40, 41, 47) . Accordingly, genetic methods have been used to identify several factors required for efficient recovery after pheromone stimulation in yeast cells. One of these, Sst2p, appears to be particularly important for this process. Loss of Sst2p can have dramatic (100-to 300-fold) effects on pheromone sensitivity. However, neither the specific role of Sst2p in signaling nor its target(s) of action is known. In order to better characterize the role of this important component of the transmembrane signaling pathway, we sought to identify SST2 mutations that antagonize pheromone action in vivo. Our objective was to find dominant alleles that would behave like steriles, allowing cells to grow in what would normally be lethally high concentrations of ␣-factor. These mutants would be useful for genetic experiments, such as those presented in FIG. 6 . SST2 regulation of Gpa1p expression. To determine if SST2 alters expression or turnover of Gpa1p, we examined Gpa1p in cells lacking SST2, expressing SST2 at high or low copy, or overexpressing SST2-1, in the presence and absence of 5 M ␣-factor. (A) Immunoblot analysis was used to monitor Gpa1p in cells that carry the sst2-⌬2 mutation (strain YDM400 containing pRS315-GAL, sst2⌬) or wild-type SST2 (YPH499/pRS315-GAL, SST2) or overexpress SST2 (YDM400/pRS315-GAL-SST2, pGAL:SST2) or SST2-1 (YDM 400/pRS315-GAL-SST2-1, pGAL:SST2-1). These data indicate that overall Gpa1p expression is not significantly altered by SST2. The shift from 56 to 54 kDa after ␣-factor administration reflects increased myristoylation of Gpa1p (18) . (B and C) To determine how SST2 influences Gpa1p stability, wild-type (B) and mutant (C) cells (strains YPH499 and YDM400, respectively) were exposed to ␣-factor (␣-MF) for 1 h or not treated, and cycloheximide was used to block further protein synthesis. Aliquots were taken at 0, 1, and 4 h after cycloheximide addition and analyzed by immunoblotting. These data indicate that SST2 does not promote Gpa1p degradation and has a slight stabilizing effect on the unmyristoylated (54-kDa) form of the protein.
VOL. 15, 1995 YEAST DESENSITIZATION MUTANTS 3641 Fig. 5 , to determine where SST2 functions in the signaling pathway. They will also be useful in biochemical experiments, which are in progress, to examine how Sst2p affects G protein function. For example, a constitutively active variant of Sst2p might bind to its target with a higher affinity, allowing copurification or coimmunoprecipitation. Sequencing of mutations with well-characterized phenotypes can also provide information about the importance of structural domains in protein function. All of the SST2 mutations described here prevent pheromone-induced growth arrest ( Fig.  2 and 5) and transcription (Fig. 4) . These changes are not due to any difference in mutant and wild-type SST2 expression (Fig. 3) . Since SST2-1, SST2-2, and SST2-3 behave similarly, the shared Pro-to-Leu substitution at position 20 must be responsible for the change in phenotype. Indeed, the loss of a Pro residue is likely to have profound effects on the secondary structure of the protein product, since it is the only naturally occurring amino acid in which the nitrogen atom forms a rigid ring structure that cannot rotate.
It is worth emphasizing that the strategy used here should be useful for characterizing the epistasis relationships of additional desensitization mutations as they become known. Already, a wide variety of mutations have been found to affect signaling. For example, MATa cells secrete a protease, the BAR1 product, that cleaves and inactivates ␣-factor (10, 33), resulting in a prolonged response to ␣-factor stimulation (8, 9) . Domains of cell surface receptors may also play a role in desensitization. Removal of the C-terminal cytoplasmic domain of the ␣-factor receptor has no effect on ligand-binding activity but prevents pheromone-stimulated phosphorylation and internalization (27, 41) , resulting in up to 100-fold-greater sensitivity to added ␣-factor. Recently, point mutations in the third cytoplasmic loop of the a-factor receptor that cause ϳ20-fold-greater sensitivity to pheromone and result in partial constitutive activation of the signaling pathway have been described (5). Finally, a deletion mutation in G␤ (ste4 ⌬310-346 ) prevents pheromone-stimulated phosphorylation of the protein and results in an approximately sixfold increase in pheromone sensitivity (12) . For all of these mutations, however, the effects on pheromone sensitivity are enhanced by the loss of SST2, suggesting distinct modes of signal regulation.
A number of alleles that reduce pheromone sensitivity have also been described. GPA1 and KSS1 (MAP kinase homolog) were originally cloned as high-copy suppressors of the pheromone-supersensitive sst2-1 mutation (15, 17) . Blumer and colleagues have described recessive mutations in the cytoplasmic domains of the ␣-factor receptor that interfere with receptor-G protein coupling, resulting in a higher EC 50 for the pheromone and enhanced recovery from pheromone-induced growth arrest (51) . The ability of these mutants to effect recovery was dependent on the functional expression of SST2, suggesting that the receptor operates upstream of Sst2p. Leberer et al. have characterized dominant negative alleles of STE4 that block pheromone-induced growth arrest yet have little effect on gene transcription or mating (30) . These mutations were isolated in a bar1⌬ sst2⌬ strain, however, and it was not determined how these phenotypes are affected by the absence of SST2.
Finally, a number of GPA1 mutations have been found to promote desensitization (29, 35, 49) . One of these, GPA1
Gly50Val
, was effective in sst2-1 (35) but not in sst2⌬ (29) cells. These findings support a model in which G␣ directly activates a downstream desensitization pathway (3, 35) . Since overexpression of Gpa1p is also allele specific with regard to SST2, and since dominant SST2 mutations suppress receptormediated but not ␤/␥-mediated signaling, we postulate that Sst2p is the ''desensitization effector'' controlled by G␣. Additional support for this model comes from recent experiments demonstrating that Gpa1p and Sst2p are both localized at the cytoplasmic surface of the Golgi and plasma membranes (18a). Thus, having established that Sst2p and Gpa1p cooperate to promote desensitization in vivo, we are developing methods to characterize this interaction in vitro. A critical question for the future is to determine how Sst2p affects G-protein subunit interactions and GTPase activity.
